Circulating miR-19, miR-27a, and miR-200c as novel biomarkers for resistance to neoadjuvant chemotherapy in gastric cancer patients: a pilot study.

Sci Rep · 2025 · PMC12614783 · PMID 41219305

Europe PMC DOI

hedged sentence

0.0980

closest p · 2.0× alpha

0.0980

boldest claim

The sentences

showed a trendp = 0.098so close (0.05 < p ≤ 0.1)

Kaplan-Meier analysis showed a trend for higher 3-year OS (89.1% vs. 67.5%; p = 0.098) and DFS (70.0% vs. 52.6%; p = 0.138) for the patients in the Responders’ group, although the differences failed for significance (Fig. 1 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.